Home›Companies›Biotech & Pharma›ProEncia

ProEncia Biotechnology Inc.

Develops treatments for adults with gum disease.

Updated Nov 9, 2026·Latest SEC filing Aug 26, 2026·Suggest an edit

About ProEncia

ProEncia is a private company based in Woodbury, Minnesota, incorporated in 2022 in Minnesota. It has reported $1,510,000 raised in one offering on Form D since August 2026. Its chief executive is Tapos Ghosh.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Oct 4, 2024Aug 26, 2026$1,510,000of $2.0M target14$107KEquity, DebtRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on ProEncia's Form D filed Aug 26, 2026.

Tapos Ghosh
Tapos Ghosh
Chief Executive Officer and director
Thomas Hoover
Thomas Hoover
Chief Clinical Officer
Austin Loeb
Austin Loeb
Chief Operations Officer
Tarun Ghosh
Tarun Ghosh
Chief Science Officer and director

Sources

  1. SECProEncia Biotechnology Inc. filing history
  2. CompanyAbout ProEncia
  3. CompanyProEncia team
  4. CompanyPre-seed funding announcement